
|Articles|June 1, 2002
New Clarinex use approved
Kenilworth, N.J. - Clarinex, a new systemic drug for treatmentof urticaria (hives), has been approved by the Food and Drug Administration(FDA), according to Schering-Plough, the drug's manufacturer.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
3
Utilizing CYP2C9 Testing and JAK Inhibitors for Alopecia Areata
4
Timing, Severity, and Therapeutic Choice in Moderate to Severe HS
5


















